» Articles » PMID: 25773161

The Kynurenine Pathway and Neurodegenerative Disease

Overview
Date 2015 Mar 17
PMID 25773161
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan is an essential amino acid required for protein synthesis, and in higher eukaryotes is also converted into the key neurotransmitters serotonin and tryptamine. However, in mammals >95% of tryptophan is metabolized through the KP, ultimately leading to the production of nicotinamide adenosine dinucleotide (NAD(+)). A number of the pathway metabolites are neuroactive; e.g. can modulate activity of several glutamate receptors and generate/scavenge free radicals. Imbalances in absolute and relative levels of KP metabolites have been strongly associated with neurodegenerative disorders including Huntington's, Alzheimer's, and Parkinson's diseases. The KP has also been implicated in the pathogenesis of other brain disorders (e.g. schizophrenia, bipolar disorder), as well as several cancers and autoimmune disorders such as HIV. Pharmacological and genetic manipulation of the KP has been shown to ameliorate neurodegenerative phenotypes in a number of model organisms, suggesting that it could prove to be a viable target for the treatment of such diseases. Here, we provide an overview of the KP, its role in neurodegeneration and the current strategies for therapeutic targeting of the pathway.

Citing Articles

Sex differences in reward-based operant conditioning performance and neurotransmitter changes following chronic sleep restriction stress in rats.

Zhang Y, Chen F, Yu M, Li Y, Chen S, Choudhary M Behav Brain Funct. 2025; 21(1):3.

PMID: 40022197 PMC: 11871611. DOI: 10.1186/s12993-025-00268-z.


Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning.

Safi A, Giunti E, Melikechi O, Xia W, Melikechi N Heliyon. 2025; 11(3):e42349.

PMID: 39981365 PMC: 11840181. DOI: 10.1016/j.heliyon.2025.e42349.


Tryptophan as a biomarker of pregnancy-related immune expression and modulation: an integrative review.

Prescott S, Billeci N, Gotcher M, Patel S, Almon A, Morgan H Front Reprod Health. 2025; 6:1453714.

PMID: 39917590 PMC: 11798915. DOI: 10.3389/frph.2024.1453714.


Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk.

Sun W, Sun P, Li J, Yang Q, Tian Q, Yuan S Schizophrenia (Heidelb). 2025; 11(1):10.

PMID: 39863625 PMC: 11762283. DOI: 10.1038/s41537-025-00559-4.


Redefining Roles: A Paradigm Shift in Tryptophan-Kynurenine Metabolism for Innovative Clinical Applications.

Tanaka M, Szabo A, Vecsei L Int J Mol Sci. 2024; 25(23).

PMID: 39684480 PMC: 11640972. DOI: 10.3390/ijms252312767.